UBS reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $203.00 (from $201.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Canaccord Genuity Reiterates Buy on Edwards Lifesciences (EW) following 3Q Results October 27, 2015 10:50 AM After-Hours Movers 10/26: (TRIV) (IDTI) (EW) Higher; (RCII) (MRVL) (MSTR) Lower (more...)October 26, 2015 5:51 PM Edwards Lifesciences (EW) Tops Q3 EPS by 9c, Q4 & FY Guidance Tops ViewsOctober 26, 2015 4:18 PM Edwards Lifesciences Reports Third Quarter ResultsOctober 26, 2015 4:15 PM Martha Marsh Appointed To Edwards Lifesciences Board Of DirectorsOctober 23, 2015 9:15 AM